<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The neuroprotective effect of YM90K, a potent AMPA receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, was examined in rats with permanent and transient occlusion of middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) using intraluminal suture occlusion method </plain></SENT>
<SENT sid="1" pm="."><plain>In rats with permanent <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusions, two types of occluders were used to compare the efficacy of YM90K </plain></SENT>
<SENT sid="2" pm="."><plain>When a 4-0 (diameter: 0.19 mm) suture was used, YM90K (20 mg kg(-1) h(-1) i.v. infusion for 4 h) significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (P&lt;0.05) and neurologic deficits (P&lt;0.05) 24 h after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was also reduced by YM90K at the same dose (P&lt;0.01) when severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by a 3-0 (diameter: 0.23 mm) suture </plain></SENT>
<SENT sid="4" pm="."><plain>In rats with transient (3 h) <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusions, a 10-mg kg(-1) h(-1) dose of YM90K that did not show significant protection in rats with permanent <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion offered neuroprotective effects </plain></SENT>
<SENT sid="5" pm="."><plain>These data demonstrate that YM90K provides cerebral neuroprotection against a wide range of ischemic insults </plain></SENT>
</text></document>